Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bebtelovimab is a humanized IgG1-λ2 antibody specifically targeting SARS-CoV-2 and has demonstrated potent neutralization against its variants, exhibiting mild-to-moderate efficacy in inhibiting COVID-19 [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Bebtelovimab is a humanized IgG1-λ2 antibody specifically targeting SARS-CoV-2 and has demonstrated potent neutralization against its variants, exhibiting mild-to-moderate efficacy in inhibiting COVID-19 [1] [2]. |
Synonyms | LY-3853113, LY-COV1404 |
Molecular Weight | N/A |
CAS No. | 2578319-11-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bebtelovimab 2578319-11-4 Microbiology/Virology SARS-CoV LY 3853113 LY-COV-1404 LY3853113 LY-3853113 LY-COV1404 LY-COV 1404 inhibitor inhibit